Platelet Glycoprotein Ib: A Zinc-Dependent Binding Protein for the Heavy Chain of High-Molecular-Weight Kininogen

[1]  R. Colman,et al.  Human Factor XII Binding to the Glycoprotein Ib-IX-V Complex Inhibits Thrombin-induced Platelet Aggregation* , 2000, The Journal of Biological Chemistry.

[2]  R. Colman,et al.  Human kininogens regulate thrombin binding to platelets through the glycoprotein Ib-IX-V complex. , 1997, Blood.

[3]  E. Peerschke,et al.  Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII: identity with the receptor that binds to the globular "heads" of C1q (gC1q-R). , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[4]  A. Schmaier,et al.  Mapping the Cell Binding Site on High Molecular Weight Kininogen Domain 5 (*) , 1995, The Journal of Biological Chemistry.

[5]  A. Schmaier,et al.  Identification of an endothelial cell binding site on kininogen domain D3. , 1995, The Journal of biological chemistry.

[6]  J. Pouysségur,et al.  Post-translational and Activation-dependent Modifications of the G Protein-coupled Thrombin Receptor (*) , 1995, The Journal of Biological Chemistry.

[7]  P. Vincent,et al.  Blood — Principles and Practice of Hematology , 1995 .

[8]  R. Colman,et al.  High molecular weight kininogen binds to Mac-1 on neutrophils by its heavy chain (domain 3) and its light chain (domain 5). , 1994, The Journal of biological chemistry.

[9]  S. Reddigari,et al.  Human Hageman factor (factor XII) and high molecular weight kininogen compete for the same binding site on human umbilical vein endothelial cells. , 1993, The Journal of biological chemistry.

[10]  J. Kutok,et al.  The thrombin receptor extracellular domain contains sites crucial for peptide ligand-induced activation. , 1993, The Journal of clinical investigation.

[11]  P. Kuna,et al.  Human high molecular weight kininogen binds to human umbilical vein endothelial cells via its heavy and light chains. , 1993, Blood.

[12]  P. Kuna,et al.  Generation of vasoactive peptide bradykinin from human umbilical vein endothelium-bound high molecular weight kininogen by plasma kallikrein. , 1992, Blood.

[13]  A. Schmaier,et al.  High molecular weight kininogen binds to platelets by its heavy and light chains and when bound has altered susceptibility to kallikrein cleavage. , 1992, Blood.

[14]  A. Schmaier,et al.  Domain 3 of kininogens contains a cell-binding site and a site that modifies thrombin activation of platelets. , 1992, The Journal of biological chemistry.

[15]  R. Colman,et al.  High molecular weight kininogen inhibits thrombin-induced platelet aggregation and cleavage of aggregin by inhibiting binding of thrombin to platelets. , 1991, Blood.

[16]  J. Kelton,et al.  Plasma glycocalicin. An aid in the classification of thrombocytopenic disorders. , 1987, The New England journal of medicine.

[17]  P. K. Smith,et al.  Measurement of protein using bicinchoninic acid. , 1985, Analytical biochemistry.

[18]  J. Griffin,et al.  Receptors for high molecular weight kininogen on stimulated washed human platelets. , 1984, Biochemistry.

[19]  B. Coller,et al.  Evidence that glycocalicin circulates in normal plasma. , 1984, The Journal of clinical investigation.

[20]  B. Coller,et al.  Studies with a murine monoclonal antibody that abolishes ristocetin- induced binding of von Willebrand factor to platelets: additional evidence in support of GPIb as a platelet receptor for von Willebrand factor , 1983 .

[21]  B. Coller,et al.  Studies with a murine monoclonal antibody that abolishes ristocetin-induced binding of von Willebrand factor to platelets: additional evidence in support of GPIb as a platelet receptor for von Willebrand factor. , 1983, Blood.

[22]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[23]  U. K. Laemmli,et al.  Cleavage of structural proteins during , 1970 .

[24]  R. R. Proctor,et al.  The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies. , 1961, American journal of clinical pathology.